News search

    E.g., 06/04/2020
    E.g., 06/04/2020
    About the CNIC
    29 Jan 2020
    CNIC is one of 4 finalists competing for €35m funding from the British Heart Foundation

    Dr. Valentín Fuster’s group will contribute to the iMAP project through the PESA-CNIC-Santander study
    Se muestra el corazón y tejidos anejos con la visualización de los vasos linfáticos y las células descendientes del segundo campo cardíaco en rojo.
    Research
    10 Jan 2020
    Development Cell: An international study discovers a new origin of lymphatic vessels in the heart

    The international team led by CNIC researchers Drs Miguel Torres and Ghislaine Lioux found that the cardiac lymphatic vasculature does not have a single origin, but is instead formed by cells originating in a variety of tissues

    De izquierda a derecha José Manuel Alfonso Almazán, Jorge García Quintanilla, Manuel Marina Breysse, José María Lillo Castellano, Julián Pérez Villacastín, David Filgueiras Rama, José Jalife y Nicasio Pérez Castellano.
    Research
    16 Dec 2019
    Europace: Personalized medicine for atrial fibrillation

    The study, published in Europace, uses signals from implantable devices—pacemakers and defibrillators—to analyze electrical signals in the heart during episodes of atrial fibrillation
    About the CNIC
    9 Jul 2019
    JACC: The CNIC is the coordinator of an international consensus document on the use of magnetic resonance imaging after a heart attack
    SRSF3 expression in adult cardiomyocytes. Pink staining shows SRSF3 expression in cell nuclei, which are stained blue. Green staining shows the presence of troponin, a sarcomere protein expressed in cardiomyocytes.
    Research
    4 Jul 2019
    Circulation Research: CNIC scientists identify an essential protein for correct heart contraction and survival

    A new study published in Circulation Research shows that loss of cardiac expression of SRSF3 leads to a critical reduction in the expression of genes related to contraction
    About the CNIC
    18 Jan 2019
    The Pro CNIC Foundation extends its commitment with the CNIC until 2028
    • ·         The Pro CNIC Foundation prolongs its commitment until 2028, with the excellent cardiovascular research carried out at the CNIC under the management of Dr. Valentín Fuster
    • ·         The innovative public-private financing formula has allowed the CNIC to reach a very high level of excellence, making it worthy of the Severo Ochoa accreditation and other international recognitions 
    • The Pro CNIC joins together 13 of the most important companies in Spain: Acciona, Santander Bank, BBVA, Endesa, Mapfre Foundation, Mutua Madrileña Foundation, Ramón Areces Foundation, Repsol Foundation, Naturgy, Inditex, "la Caixa", Prisa and Telefónica.
    Prof. Eldad Tzahor
    Research
    18 Oct 2018
    Prof. Eldad Tzahor: “We have discovered the recipe to create a new heart”

    Professor Eldad Tzahor, Director of the Cellular and Molecular Biology Laboratory at the Weizmann Institute of Science, in Rehovo (Israel).
    About the CNIC
    1 Oct 2018
    CNIC researcher Guadalupe Sabio receives the IV AstraZeneca Foundation Jóvenes Investigadores prize

    The Fundación AstraZeneca young researcher awards were created to give scientists the opportunities they deserve
    Dr. Andrés Hidalgo
    About the CNIC
    4 Jul 2018
    CNIC coordinates a project from the Leducq Foundation

     ‘Clonal hematopoiesis and atherosclerosis’ will receive a total funding of $6,000,000, of which $712,500 correspond to the CNIC
    De izda. a dcha.: José Antonio Enriquez, María del Mar Muñoz, Fátima Sánchez-Cabo, Luis Jesús Jiménez-Borreguero, Rocío Nieto-Arellano, Andrés González-Guerra, Carlos Torroja, José María Castellanos, y Concepción Jiménez.
    Research
    3 Apr 2018
    Science Translational Medicine: CNIC scientists identify a promising target for the treatment of heart failure

    The study is published in Science Translational Medicine and was conducted by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)